Generic Medicine Info
May be taken with or without food.
Pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, GI haemorrhage, and obstructive uropathies of the lower urinary tract.
Special Precautions
Patient w/ suspected glaucoma (esp closed angle glaucoma); serious, uncontrolled, obstructive disorders of the lower urinary tract. Childn. Pregnancy and lactation. Patient Counselling This drug may cause drowsiness and blurred vision, if affected, do not drive or operate machinery.
Adverse Reactions
Nervous: Drowsiness, headache, vertigo, nervousness, confusion. CV: Palpitation, tachycardia. GI: Nausea, vomiting, dry mouth/throat, abdominal pain, constipation. Resp: Reduced bronchial secretions. Genitourinary: Dysuria. Haematologic: Leucopenia, eosinophilia. Ophthalmologic: Increased intraocular tension, accommodation disturbance, blurred vision, photophobia. Dermatologic: Dryness, flushing, urticaria and other dermatoses. Others: Hyperpyrexia.
Drug Interactions
Increased CNS effects w/ other sedative agents.
ATC Classification
G04BD02 - flavoxate ; Belongs to the class of urinary antispasmodics.
Disclaimer: This information is independently developed by CIMS based on flavoxate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in